H Lundbeck A/S HLUKF:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
37.56quote price arrow down-1.33 (-3.43%)
Volume
101
52 week range
26.09 - 43.17

...

Loading . . .

KEY STATS

  • Open38.71
  • Day High38.71
  • Day Low37.56
  • Prev Close38.90
  • 52 Week High43.17
  • 52 Week High Date02/16/21
  • 52 Week Low26.09
  • 52 Week Low Date03/17/20
  • Market Cap7,603.76M
  • Shares Out198.7M
  • 10 Day Average Volume665.91
  • Dividend0.40
  • Dividend Yield1.07%
  • Beta
  • 1 Year % Change5.89

RATIOS/PROFITABILITY

  • EPS (TTM)1.31
  • P/E (TTM)28.74
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/25/2020
  • Div Amount4.10
  • Split Date-
  • Split Factor-

Latest H Lundbeck A/S News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s...
Lars Rasmussen
Chairman
Lene Skole-Soerensen
Vice Chairman
Deborah Dunsire M.D.
President
Anders Goetzsche
Chief Financial Officer
Jacob Tolstrup
Executive Vice President
Address
Ottiliavej 9
Valby
2500
Denmark